In our results, expression of Tgfb1mRNA was downregulated in PFD treated mice, supporting the evidence that TGF-β1 is an important target [29,30,31] and its decreased expression could be associated with less dermal damage. The gene discussed is TGFB1; the disease is polyostotic fibrous dysplasia.